Presentation NY Valves 2025 Management of HALT After TAVR: Anticoagulation, Which Agent, How Long Presenter: George D. Dangas June 26, 2025
News Conference News TCT 2024 In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI Yael L. Maxwell October 29, 2024
News Daily News Symplicity Spyral Approved: FDA Clears Second Renal Denervation System Todd Neale November 20, 2023
News Daily News Cardiology Society Leaders Expand on Vision for New Medical Board Todd Neale October 05, 2023
Presentation Complex Coronary Cases 2023 Board Review Questions Presenter: George Dangas June 14, 2023
News Conference News SCAI 2023 Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis L.A. McKeown May 30, 2023
News Conference News CRT 2023 In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’ Yael L. Maxwell March 01, 2023
Presentation TCT 2022 Keynote Lecture: Essentials of Calcium Management Presenter: Annapoorna Kini September 18, 2022
News Conference News ESC 2022 ‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR Shelley Wood August 28, 2022
Presentation TVT 2022 Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations Presenter: George Dangas June 10, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
Presentation TCT 2021 Case #2: Antiplatelet Therapy Disruption Challenges After Stenting Presenter: George Dangas November 05, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
Presentation TVT 2021 Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR Presenter: George Dangas July 21, 2021